Researcher finds help for Alzheimer’s-associated agitation with new FDA-approved treatment

A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer’s dementia.

Leave A Comment

Your email address will not be published. Required fields are marked *